Hydroxylated Tropolones Inhibit Hepatitis B Virus Replication by Blocking Viral Ribonuclease H Activity

Hepatitis B virus (HBV) remains a major human pathogen despite the development of both antiviral drugs and a vaccine, in part because the current therapies do not suppress HBV replication far enough to eradicate the virus. Here, we screened 51 troponoid compounds for their ability to suppress HBV RN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Lu, Gaofeng, Lomonosova, Elena, Cheng, Xiaohong, Moran, Eileen A., Meyers, Marvin J., Le Grice, Stuart F. J., Thomas, Craig J., Jiang, Jian-kang, Meck, Christine, Hirsch, Danielle R., D'Erasmo, Michael P., Suyabatmaz, Duygu M., Murelli, Ryan P., Tavis, John E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335860/
https://ncbi.nlm.nih.gov/pubmed/25451058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04617-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados